INMB(INMB)
INMB
Q4 2026 EPS Estimate
$-0.17
Oct 29, 2026 · Reports after close
Revenue Estimate
$2M
FY2029E EPS$0.69
FY2030E EPS$1.81
Analyst Sentiment
Wall St. Consensus
Buy9 analysts·Limited coverage
64
Score
6 Buy (67%)2 Hold (22%)1 Sell (11%)
Rating Breakdown
Strong Buy
00%
Buy
667%
Hold
222%
Sell
111%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$22.00
+913.8%
Consensus
$22.00
+913.8%
Bull
$22.00
+913.8%
12-Month Target Range9 analysts
$22.00$22.00$22.00
Current $2.17Consensus
Current Price
$2.17
Upside to Consensus
$19.83
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+7055.02%
EPS—
FY2028
Rev+162.69%
EPS—
FY2029
Rev+285.29%
EPS—
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $133,333 | $10M | $25M | $97M | $169M |
| Low | $96,832 | $7M | $18M | $70M | $122M |
| High | $169,833 | $12M | $32M | $123M | $215M |
| EBITDA Avg | $-133,333 | $-10M | $-25M | $-97M | $-169M |
| Low | $-169,833 | $-12M | $-32M | $-123M | $-215M |
| High | $-96,832 | $-7M | $-18M | $-70M | $-122M |
| EBIT Avg | $-133,333 | $-10M | $-25M | $-97M | $-169M |
| Low | $-169,833 | $-12M | $-32M | $-123M | $-215M |
| High | $-96,832 | $-7M | $-18M | $-70M | $-122M |
| Net Income Avg | $-23M | $-23M | $-15M | $18M | $48M |
| Low | $-27M | $-24M | $-18M | $12M | $31M |
| High | $-13M | $-22M | $-9M | $25M | $65M |
| EPS Avg | $-0.75 | $-0.86 | $-0.50 | $0.69 | $1.81 |
| Low | $-1.02 | $-0.90 | $-0.67 | $0.44 | $1.17 |
| High | $-0.49 | $-0.82 | $-0.33 | $0.94 | $2.45 |
| Analysts (Rev / EPS) | 4 / 2 | 3 / 2 | 2 / 2 | 1 / 1 | 1 / 1 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $2M | $2M | — | — | — | $15M |
| Low | $2M | $2M | — | — | — | $15M |
| High | $2M | $2M | — | — | — | $15M |
| EBITDA Avg | $-2M | $-2M | — | — | — | $-15M |
| Low | $-2M | $-2M | — | — | — | $-15M |
| High | $-2M | $-2M | — | — | — | $-15M |
| EBIT Avg | $-2M | $-2M | — | — | — | $-15M |
| Low | $-2M | $-2M | — | — | — | $-15M |
| High | $-2M | $-2M | — | — | — | $-15M |
| Net Income Avg | $-6M | $-5M | $-7M | $-3M | $-3M | $-3M |
| Low | $-6M | $-5M | $-7M | $-3M | $-3M | $-3M |
| High | $-6M | $-5M | $-7M | $-3M | $-3M | $-3M |
| EPS Avg | $-0.21 | $-0.20 | $-0.24 | $-0.13 | $-0.13 | $-0.13 |
| Low | $-0.21 | $-0.20 | $-0.24 | $-0.13 | $-0.13 | $-0.13 |
| High | $-0.21 | $-0.20 | $-0.24 | $-0.13 | $-0.13 | $-0.13 |
| Analysts (Rev / EPS) | 3 / 1 | 3 / 1 | — / 1 | — / 1 | — / 1 | 3 / 1 |